Alps Advisors Inc Xencor Inc Transaction History

Alps Advisors Inc

$17.2 Billion
Q1 2025

A detailed history of Alps Advisors Inc transactions in Xencor Inc stock. As of the latest transaction made, Alps Advisors Inc holds 51,459 shares of XNCR stock, worth $411,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,459

Previous 56,585 9.06%

Holding current value

$411,672

Previous $1.3 Million 57.92%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$10.64 - $24.13 $54,540 - $123,690	-5,126 Reduced 9.06%	51,459 $547,000
Q4 2024 Feb 13, 2025	BUY	$19.43 - $26.84 $165,193 - $228,193	8,502 Added 17.68%	56,585 $1.3 Million
Q3 2024 Nov 12, 2024	SELL	$15.7 - $21.65 $219 - $303	-14 Reduced 0.03%	48,083 $966,000
Q2 2024 Aug 13, 2024	BUY	$18.21 - $24.5 $90,886 - $122,279	4,991 Added 11.58%	48,097 $910,000
Q1 2024 May 14, 2024	BUY	$18.65 - $26.52 $53,749 - $76,430	2,882 Added 7.16%	43,106 $953,000
Q4 2023 Feb 14, 2024	SELL	$16.53 - $21.42 $74,037 - $95,940	-4,479 Reduced 10.02%	40,224 $853,000
Q3 2023 Nov 14, 2023	BUY	$20.08 - $25.39 $6,244 - $7,896	311 Added 0.7%	44,703 $900,000
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $119,862 - $144,686	4,839 Added 12.23%	44,392 $1.11 Million
Q1 2023 May 10, 2023	SELL	$25.95 - $36.95 $27,688 - $39,425	-1,067 Reduced 2.63%	39,553 $1.1 Million
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $199,757 - $248,669	8,058 Added 24.75%	40,620 $1.06 Million
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $67,901 - $89,469	-2,758 Reduced 7.81%	32,562 $846,000
Q2 2022 Aug 11, 2022	BUY	$19.74 - $29.01 $697,216 - $1.02 Million	35,320 New	35,320 $967,000
Q1 2022 May 16, 2022	SELL	$26.68 - $41.63 $1.81 Million - $2.82 Million	-67,679 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$33.67 - $43.44 $128,114 - $165,289	-3,805 Reduced 5.32%	67,679 $2.72 Million
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $144,055 - $167,696	-4,700 Reduced 6.17%	71,484 $2.34 Million
Q2 2021 Aug 11, 2021	SELL	$34.33 - $44.68 $983,348 - $1.28 Million	-28,644 Reduced 27.32%	76,184 $2.63 Million
Q1 2021 May 07, 2021	BUY	$40.81 - $53.88 $55,583 - $73,384	1,362 Added 1.32%	104,828 $4.51 Million
Q4 2020 Feb 03, 2021	BUY	$36.63 - $47.63 $3.79 Million - $4.93 Million	103,466 New	103,466 $4.51 Million

Others Institutions Holding XNCR

# of Institutions

210

Shares Held

78.4M

Call Options Held

3.4K

Put Options Held

1.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $478M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Xencor Inc Transaction History